What you should know:
1. Takeda spun off several of its non-core business lines after closing its deal for Shire in 2019. The company has committed to selling $10 billion of its non-core assets.
2. Takeda acquired Shire for $62 billion, which made it one of the most indebted companies in the world.
3. Blackstone acquired a portfolio of drugs that made a reported $567 million (60 billion yen) in 2019.
More articles on surgery centers:
3 ASC developments worth over $10M
7 critical steps for financial success in your ASC
10 most common procedures in ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
